DE69636096D1 - Verfahren zur behandlung von gefässrestenose durch inhalieren von stickoxid - Google Patents

Verfahren zur behandlung von gefässrestenose durch inhalieren von stickoxid

Info

Publication number
DE69636096D1
DE69636096D1 DE69636096T DE69636096T DE69636096D1 DE 69636096 D1 DE69636096 D1 DE 69636096D1 DE 69636096 T DE69636096 T DE 69636096T DE 69636096 T DE69636096 T DE 69636096T DE 69636096 D1 DE69636096 D1 DE 69636096D1
Authority
DE
Germany
Prior art keywords
inhaling
treating vegetable
vegetable remains
stain
oxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69636096T
Other languages
English (en)
Other versions
DE69636096T2 (de
Inventor
M Zapol
D Bloch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23537703&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69636096(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by General Hospital Corp filed Critical General Hospital Corp
Application granted granted Critical
Publication of DE69636096D1 publication Critical patent/DE69636096D1/de
Publication of DE69636096T2 publication Critical patent/DE69636096T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69636096T 1995-02-16 1996-02-08 Verfahren zur behandlung von gefässrestenose durch inhalieren von stickstoffmonoxid Expired - Lifetime DE69636096T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US389304 1995-02-16
US08/389,304 US6063407A (en) 1995-02-16 1995-02-16 Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
PCT/US1996/001745 WO1996025184A1 (en) 1995-02-16 1996-02-08 Treatment of vascular thrombosis and restenosis with inhaled nitric oxide

Publications (2)

Publication Number Publication Date
DE69636096D1 true DE69636096D1 (de) 2006-06-08
DE69636096T2 DE69636096T2 (de) 2006-12-07

Family

ID=23537703

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69636096T Expired - Lifetime DE69636096T2 (de) 1995-02-16 1996-02-08 Verfahren zur behandlung von gefässrestenose durch inhalieren von stickstoffmonoxid

Country Status (19)

Country Link
US (2) US6063407A (de)
EP (1) EP0810884B1 (de)
JP (1) JP3956055B2 (de)
KR (1) KR100426528B1 (de)
CN (1) CN1327826C (de)
AR (1) AR000960A1 (de)
AT (1) ATE324866T1 (de)
AU (1) AU690425B2 (de)
BR (1) BR9607616A (de)
CZ (1) CZ289677B6 (de)
DE (1) DE69636096T2 (de)
DK (1) DK0810884T3 (de)
ES (1) ES2263159T3 (de)
FI (1) FI119912B (de)
HU (1) HUP9802093A3 (de)
NO (1) NO315355B1 (de)
PT (1) PT810884E (de)
WO (1) WO1996025184A1 (de)
ZA (1) ZA961183B (de)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331543B1 (en) 1996-11-01 2001-12-18 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
US5958926A (en) 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
CA2270118A1 (en) * 1996-11-01 1998-05-14 Nitromed Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
USRE37234E1 (en) 1996-11-01 2001-06-19 Nitromed, Inc. Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses
WO1999009992A1 (fr) * 1997-08-27 1999-03-04 Yoshitomi Pharmaceutical Industries, Ltd. Promoteurs de neovascularisation
US5994444A (en) * 1997-10-16 1999-11-30 Medtronic, Inc. Polymeric material that releases nitric oxide
US6656452B1 (en) 1997-10-21 2003-12-02 The General Hospital Corporation Use of inhaled NO as anti-inflammatory agent
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
EP1128769A4 (de) * 1998-11-06 2007-08-01 Univ Rochester Verfahren zur verbesserung der blutzirkulation in ischämischem gewebe
US20070086954A1 (en) * 1998-11-23 2007-04-19 Miller Christopher C Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
CA2254645A1 (en) * 1998-11-23 2000-05-23 Pulmonox Medical Corporation Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
US6612306B1 (en) 1999-10-13 2003-09-02 Healthetech, Inc. Respiratory nitric oxide meter
US7516742B2 (en) * 1999-11-24 2009-04-14 Cardinal Health 207, Inc. Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients with intermittent dosing
CA2410632A1 (en) 2000-06-22 2001-12-27 David S. Garvey Nitrosated and nitrosylated taxanes, compositions and methods of use
US6601580B1 (en) * 2000-06-28 2003-08-05 The General Hospital Corporation Enhancing therapeutic effectiveness of nitric oxide inhalation
EA005649B1 (ru) * 2000-08-11 2005-04-28 Дэвид Р. Уитлок Композиции, содержащие аммиакокисляющие бактерии, увеличивающие продуцирование окиси азота и предшественников окиси азота, и способы их использования
WO2002024208A1 (en) * 2000-09-20 2002-03-28 Aquamed Technologies, Inc. Compositions comprising lignin and methods of making and using the same
US6620106B2 (en) 2000-09-29 2003-09-16 Healthetech, Inc. Indirect calorimetry system
WO2002034259A1 (en) * 2000-10-26 2002-05-02 Fournier Laboratories Ireland Limited Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
US6432077B1 (en) 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
US7335181B2 (en) * 2000-12-26 2008-02-26 Pulmonox Technologies Corporation Nitric oxide decontamination of the upper respiratory tract
US7122018B2 (en) * 2000-12-26 2006-10-17 Sensormedics Corporation Device and method for treatment of wounds with nitric oxide
CA2451266A1 (en) 2001-06-21 2003-01-03 Beth Israel Deaconess Medical Center Inc. Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
US20070173460A1 (en) * 2001-09-20 2007-07-26 Oculus Innovative Sciences, Inc. Compositions comprising lignin and methods of making and using the same
US20030070674A1 (en) * 2001-10-12 2003-04-17 Bryan Perry Use of aerosolized compounds in the treatment of exercise induced pulmonary hemorrhage in an equine
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
US6472390B1 (en) * 2001-11-13 2002-10-29 Duke University Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
US6627602B2 (en) * 2001-11-13 2003-09-30 Duke University Preventing desensitization of receptors
US20040110691A1 (en) * 2001-11-13 2004-06-10 Stamler Jonathan S. Thiol reactive agents as a therapeutic modality
CN1308438C (zh) * 2002-01-11 2007-04-04 大卫·R·怀特洛克 含有氨氧化细菌的化合物以及使用的方法
US7086397B2 (en) * 2002-02-16 2006-08-08 Graham Lindley Spruiell Patient usable emergency medical kit
PL375161A1 (en) * 2002-06-21 2005-11-28 University Of Pittsburgh Of The Commonwealth System Of Higher Education Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
US7531133B2 (en) * 2002-09-10 2009-05-12 Pulmonox Technologies Corporation Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma
US9138707B2 (en) 2002-12-10 2015-09-22 Sy Kimball Portable, nitric oxide generator
AU2004255268B2 (en) * 2003-07-09 2010-04-01 Loma Linda University Use of nitrite salts for the treatment of cardiovascular conditions
EP1667646A4 (de) * 2003-09-26 2007-07-04 David R Whitlock Verfahren zur verwendung von ammoniak-oxidierenden bakterien
CN100475275C (zh) * 2004-01-05 2009-04-08 董永华 肿瘤血管栓塞剂及其储存和释放装置
WO2005077005A2 (en) * 2004-02-04 2005-08-25 The General Hospital Corporation Enhancing the effectiveness of an inhaled therapeutic gas
WO2005110441A2 (en) * 2004-05-11 2005-11-24 Sensormedics Corporation Intermittent dosing of nitric oxide gas
US8518457B2 (en) * 2004-05-11 2013-08-27 Pulmonox Technologies Corporation Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US20070154570A1 (en) * 2004-09-29 2007-07-05 Miller Christopher C Use of nitric oxide in the treatment and disinfection of biofilms
WO2006125123A2 (en) * 2005-05-19 2006-11-23 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
WO2007057763A2 (en) * 2005-11-18 2007-05-24 Pulmonox Technologies Corporation Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant
US8079998B2 (en) * 2006-10-20 2011-12-20 Pulmonox Technologies Corporation Methods and devices for the delivery of therapeutic gases including nitric oxide
JP5697335B2 (ja) 2006-11-07 2015-04-08 ザ ジェネラル ホスピタル コーポレイション 血管作動性酸素運搬体に誘導される血管収縮の減弱
US20080193566A1 (en) * 2007-02-09 2008-08-14 Miller Christopher C Use of high dose concentrations of gaseous nitric oxide
JP2011507968A (ja) * 2007-12-27 2011-03-10 エイヤーズ ファーマシューティカルズ、インク． エアロゾル化ニトライトおよび一酸化窒素供与性化合物ならびにそれらの使用
US8434475B2 (en) * 2008-01-31 2013-05-07 Genosys, Inc. Nitric oxide reactor and distributor apparatus and method
US8720436B2 (en) * 2008-01-31 2014-05-13 Genosys, Inc. Nitric oxide gel apparatus and method
US9649467B2 (en) 2008-01-31 2017-05-16 Syk Technologies, Llc Nitric oxide reactor and distributor apparatus and method
US8501090B2 (en) * 2008-03-24 2013-08-06 Christian S. Minton Anti-microbial gas apparatus and method
AU2009273911B2 (en) * 2008-07-24 2016-09-08 VERO Biotech LLC. Methods for diagnosing and treating a heart condition in a patient
CA3130908A1 (en) 2009-06-30 2010-12-30 Mallinckrodt Hospital Products IP Limited Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
US8685467B2 (en) 2010-08-03 2014-04-01 J. W. Randolph Miller Nitric oxide generation, dilution, and topical application apparatus and method
US20120107423A1 (en) 2010-11-01 2012-05-03 Ino Therapeutics Llc Methods of Using Inhaled Nitric Oxide Gas for Treatment of Acute Respiratory Distress Syndrome
JP6389125B2 (ja) 2011-11-07 2018-09-12 ザ ジェネラル ホスピタル コーポレイション 赤血球の処理法
US10517817B2 (en) 2013-05-09 2019-12-31 Syk Technologies, Llc Deep topical systemic nitric oxide therapy apparatus and method
US9517275B2 (en) 2013-09-30 2016-12-13 Northwestern University Targeted therapy for the prevention of restenosis in the cardiovascular system
CA2936490C (en) 2014-01-10 2022-10-04 Ino Therapeutics Llc Methods of using inhaled nitric oxide gas for treatment of acute respiratory distress syndrome in children
US11225640B2 (en) 2014-04-15 2022-01-18 Aobiome Llc Ammonia oxidizing bacteria for treatment of psoriasis
US20170037363A1 (en) 2014-04-15 2017-02-09 Aobiome Llc Ammonia-oxidizing nitrosomonas eutropha strain d23
US10668015B2 (en) * 2015-01-20 2020-06-02 Incarda Therapeutics, Inc. Unit aerosol doses for anticoagulation
DK3407900T3 (da) 2016-01-27 2024-04-02 Syk Tech Llc Apparatur til topisk anvendelse af kvældstofoxid samt fremgangsmåder
WO2023081681A1 (en) * 2021-11-03 2023-05-11 Baxter International Inc. Nitric oxide donors for use in surgical recovery

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3785377A (en) * 1970-11-12 1974-01-15 S Jorgensen Plant, preferably for anaesthesia
US4010897A (en) * 1976-03-31 1977-03-08 Charles F. Kettering Foundation Method and apparatus for home production and application of nitrogen fertilizer
IL57239A (en) * 1979-05-08 1982-04-30 Alamaro Moshe Production of nitric oxides
US4297123A (en) * 1980-02-07 1981-10-27 Wyse Harold G Method and apparatus for producing a nitrate fertilizer
US4336798A (en) * 1980-10-06 1982-06-29 Anthony V. Beran Medical corrugated respiratory tube
SE438261B (sv) * 1981-07-08 1985-04-15 Draco Ab Anvendning i dosinhalator av ett perforerat membran
US4534343A (en) * 1984-01-27 1985-08-13 Trutek Research, Inc. Metered dose inhaler
US4592348A (en) * 1984-12-17 1986-06-03 Waters Iv William C Aerosol inhaler
CN87107609A (zh) * 1987-11-12 1988-09-14 赵树杰 脑血栓治疗仪
US4852561A (en) * 1988-07-27 1989-08-01 Sperry C R Inhalation device
US4877589A (en) * 1988-09-19 1989-10-31 Hare Louis R O Nitrogen fixation by electric arc and catalyst
US4915915A (en) * 1988-10-11 1990-04-10 Treharne Richard W Water-powdered piezoelectric unit for producing nitrogen fertilizer
US4954526A (en) * 1989-02-28 1990-09-04 The United States Of America As Represented By The Department Of Health And Human Services Stabilized nitric oxide - primary amine complexes useful as cardiovascular agents
US5208233A (en) * 1989-09-15 1993-05-04 The United States Of America As Represented By The Department Of Health And Human Services Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
US5155137A (en) * 1990-09-20 1992-10-13 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Complexes of nitric oxide with polyamines
DE69133584D1 (de) * 1990-12-05 2007-12-13 Gen Hospital Corp Vorrichtung zum Behandeln einen Lungengefässverengung und von Asthma
US5396882A (en) * 1992-03-11 1995-03-14 The General Hospital Corporation Generation of nitric oxide from air for medical uses
US5570683A (en) * 1990-12-05 1996-11-05 The General Hospital Corporation Methods and devices for treating pulmonary vasoconstriction and asthma
US5536241A (en) * 1990-12-05 1996-07-16 The General Hospital Corporation Methods and devices for relaxing smooth muscle contractions
IL101406A (en) * 1991-03-29 1998-02-08 Brigham & Womens Hospital Pharmaceutical compositions containing s-nitrosothiol derivatives
US5385937A (en) * 1991-04-10 1995-01-31 Brigham & Women's Hospital Nitrosation of homocysteine as a method for treating homocysteinemia
US5185376A (en) * 1991-09-24 1993-02-09 The United States Of America As Represented By The Department Of Health And Human Services Therapeutic inhibition of platelet aggregation by nucleophile-nitric oxide complexes and derivatives thereof
WO1993012068A1 (en) * 1991-12-11 1993-06-24 Brigham And Women's Hospital S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
US5650447A (en) * 1992-08-24 1997-07-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nitric oxide-releasing polymers to treat restenosis and related disorders
CN1083707A (zh) * 1992-09-05 1994-03-16 沈阳康达制药厂 一种脑血栓片的生产工艺
FR2695831B1 (fr) * 1992-09-24 1994-11-10 Air Liquide Installation et procédé de fourniture d'un mélange gazeux aux voies respiratoires d'un utilisateur.
WO1994016729A1 (en) * 1993-01-28 1994-08-04 Neorx Corporation Targeted nitric oxide pathway or nitric oxide synthase modulation
US5427797A (en) * 1993-04-06 1995-06-27 Brigham And Women's Hospital Systemic effects of nitric oxide inhalation
US5861168A (en) * 1993-06-11 1999-01-19 The Board Of Trustees Of The Leland Stanford Junior University Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
US5428070A (en) * 1993-06-11 1995-06-27 The Board Of Trustees Of The Leland Stanford Junior University Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production of activity
DE69423905T2 (de) * 1993-07-06 2000-10-05 Aerocrine Ab, Danderyd System zur feststellung von no-pegeln in ausgeatmeter luft und diagnostische verfahren für zu abnormalen no-pegeln in beziehung stehenden abweichungen
DE4327732C1 (de) * 1993-08-18 1994-09-01 Messer Griesheim Gmbh NO-haltiges Gasgemisch zur Behandlung pulmonaler Erkrankungen
DE4327731C1 (de) * 1993-08-18 1994-11-10 Messer Griesheim Gmbh NO-haltiges Gasgemisch zur Behandlung pulmonaler Erkrankungen
GB9320978D0 (en) * 1993-10-12 1993-12-01 Higenbottam Timohy W Nitric oxide treatment
US5681278A (en) * 1994-06-23 1997-10-28 Cormedics Corp. Coronary vasculature treatment method
US5660873A (en) * 1994-09-09 1997-08-26 Bioseal, Limited Liability Corporaton Coating intraluminal stents
US5521191A (en) * 1994-10-17 1996-05-28 Washington University Method for treatment of arterial stenosis
EP0799051B1 (de) * 1994-12-12 2005-07-27 Omeros Corporation Bespüllungslösung und deren verwendung zur perioperativen hemmung von schmerzen, entzündungen und spasmen an einer wunde
US5823180A (en) * 1995-04-03 1998-10-20 The General Hospital Corporation Methods for treating pulmonary vasoconstriction and asthma
ATE331505T1 (de) * 1996-04-05 2006-07-15 Gen Hospital Corp Behandlung einer hämoglobinstörung

Also Published As

Publication number Publication date
DE69636096T2 (de) 2006-12-07
FI973357A0 (fi) 1997-08-15
AR000960A1 (es) 1997-08-27
CN1174513A (zh) 1998-02-25
DK0810884T3 (da) 2006-08-28
AU4777596A (en) 1996-09-04
CZ259897A3 (cs) 1998-05-13
CZ289677B6 (cs) 2002-03-13
US5904938A (en) 1999-05-18
NO315355B1 (no) 2003-08-25
HUP9802093A3 (en) 2001-02-28
ATE324866T1 (de) 2006-06-15
FI973357A (fi) 1997-08-15
EP0810884A4 (de) 2002-05-08
WO1996025184A1 (en) 1996-08-22
JP3956055B2 (ja) 2007-08-08
CN1327826C (zh) 2007-07-25
AU690425B2 (en) 1998-04-23
BR9607616A (pt) 1998-06-09
EP0810884B1 (de) 2006-05-03
US6063407A (en) 2000-05-16
KR19980702187A (ko) 1998-07-15
ZA961183B (en) 1996-12-17
ES2263159T3 (es) 2006-12-01
MX9706257A (es) 1997-11-29
JPH11500125A (ja) 1999-01-06
NO973768D0 (no) 1997-08-15
KR100426528B1 (ko) 2004-06-30
FI119912B (fi) 2009-05-15
PT810884E (pt) 2006-08-31
NO973768L (no) 1997-10-15
HUP9802093A2 (hu) 2000-06-28
EP0810884A1 (de) 1997-12-10

Similar Documents

Publication Publication Date Title
DE69636096D1 (de) Verfahren zur behandlung von gefässrestenose durch inhalieren von stickoxid
DE69425372D1 (de) Verfahren zur behandlung endo-ostealer materialien
DE69603838D1 (de) Verfahren zur behandlung von gasen
ATE225185T1 (de) Verfahren zur behandlung von allergischem asthma
DE69331469D1 (de) Verfahren zur behandlung von abfällen
DE69701714D1 (de) Verfahren zur behandlung von glassubstraten
DE69726289D1 (de) Verfahren und zusammensetzung zur behandlung von substraten bezüglich benetzbarkeit
DE69010893D1 (de) Verfahren zur behandlung von koks sowie löschen desselben.
DE69631258D1 (de) Verfahren zum Entfernen von Verunreinigungen durch Bürsten
DE69535022D1 (de) Verfahren zur verbesserung von destillat
ATE205425T1 (de) Verfahren zur behandlung von festen abfällen
DE69417018D1 (de) Verfahren zur behandlung von teilchenmaterial
DE69228054D1 (de) Orthomolekulares verfahren zur behandlung von sichelzellanämie
ATE232919T1 (de) Zusammensetzung zur behandlung von wäsche sowie verfahren hierfür
DE69518824D1 (de) Verfahren zur behandlung von bremsscheiben
DE69730870D1 (de) Verfahren und vorrichtung zur behandlung von abällen durch vergasung
DE59601109D1 (de) Verfahren zum behandeln von hausmüll
ATE371453T1 (de) Verfahren zur behandlung von okularen neovaskularen erkrankungen
DE69609082D1 (de) Verfahren zur behandlung von abfällen
DE58902128D1 (de) Verfahren zur behandlung von klaerschlamm.
DE69629955D1 (de) Verfahren zur behandlung von holz
DE69030584D1 (de) Verfahren sowie zusammensetzungen zur behandlung mit vitaminmineral
DE69802904D1 (de) Verbessertes verfahren zur behandlung von aluminiummonohydratreichen bauxiten
DE69701726D1 (de) Verfahren zur behandlung von knitterempfindlichen geweben
ATE239696T1 (de) Verfahren zur behandlung von textilmaterialien

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: DF-MP, 80333 MUENCHEN